X T L Biopharmaceuticals reported $-385K in Pre-Tax Profit for its fiscal quarter ending in December of 2024.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Bioline Rx USD -977K 2.96M Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
X T L Biopharmaceuticals USD -385K 168K Dec/2024